Global Stock News

Vertex Stock: Slowing Growth, But It’s Attractively Valued Now

Article feature image

Vertex Stock: Slowing Growth, But It’s Attractively Valued Now

koto_feja/E+ via Getty Images
Investment Thesis
Vertex Pharmaceuticals Incorporated (VRTX) is a biotech company specializing in treating genetic Cystic Fibrosis. The company sells four different combinations of drugs to treat patients with Cystic Fibrosis,…

Click here to view the original article.

Share this article

Scroll to Top